![Wolfgang Schoenfeld](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wolfgang Schoenfeld
Präsident bei EUCODIS Bioscience GmbH Deutschland
Aktive Positionen von Wolfgang Schoenfeld
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EUCODIS Bioscience GmbH Deutschland
![]() EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria. | Präsident | 01.01.2004 | - |
Karriereverlauf von Wolfgang Schoenfeld
Ehemalige bekannte Positionen von Wolfgang Schoenfeld
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ruhr-Universität Bochum | Corporate Officer/Principal | - | - |
BAYER AG | Corporate Officer/Principal | 01.01.1991 | - |
Mixis Genetics Ltd
![]() Mixis Genetics Ltd Pharmaceuticals: OtherHealth Technology Part of Teva Pharmaceutical Industries Ltd., Mixis Genetics Ltd is a French company that develops medicinal chemicals and botanical products. The company is based in Paris, France. The CEO of the company is Gilles Amsallem. Mixis Genetics was acquired by PLIVA dd, part of Teva Pharmaceutical Industries Ltd. from October 24, 2006 on April 01, 1999 for $3.26 million. | Corporate Officer/Principal | - | - |
PLIVA dd
![]() PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Corporate Officer/Principal | - | - |
EUCODIS Bioscience GmbH
![]() EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Gründer | 01.01.2004 | - |
Präsident | 01.01.2007 | - |
Ausbildung von Wolfgang Schoenfeld
RWTH Aachen University | Doctorate Degree |
Statistik
International
Deutschland | 5 |
Österreich | 2 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 4 |
President | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BAYER AG | Health Technology |
Private Unternehmen | 4 |
---|---|
EUCODIS Bioscience GmbH Deutschland
![]() EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria. | Commercial Services |
EUCODIS Bioscience GmbH
![]() EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Retail Trade |
Mixis Genetics Ltd
![]() Mixis Genetics Ltd Pharmaceuticals: OtherHealth Technology Part of Teva Pharmaceutical Industries Ltd., Mixis Genetics Ltd is a French company that develops medicinal chemicals and botanical products. The company is based in Paris, France. The CEO of the company is Gilles Amsallem. Mixis Genetics was acquired by PLIVA dd, part of Teva Pharmaceutical Industries Ltd. from October 24, 2006 on April 01, 1999 for $3.26 million. | Health Technology |
PLIVA dd
![]() PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Health Technology |
- Börse
- Insiders
- Wolfgang Schoenfeld
- Erfahrung